{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T07:18:17Z","timestamp":1790320697511,"version":"4.1.0"},"reference-count":17,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1016\/j.revmed.2010.10.354","type":"journal-article","created":{"date-parts":[[2010,12,4]],"date-time":"2010-12-04T04:31:07Z","timestamp":1291437067000},"page":"271-274","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Polymorphisme de l\u2019IL-28B et infection par le virus de l\u2019h\u00e9patite C\u00a0: impact sur la clairance virale prolong\u00e9e, spontan\u00e9e et apr\u00e8s traitement antiviral"],"prefix":"10.1016","volume":"32","author":[{"given":"P.","family":"Halfon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Cacoub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.revmed.2010.10.354_bib0005","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1002\/hep.1840360706","article-title":"Natural history of chronic hepatitis C","volume":"36","author":"Seeff","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.revmed.2010.10.354_bib0010","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1056\/NEJMoa020047","article-title":"Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection","volume":"347","author":"Fried","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.revmed.2010.10.354_bib0015","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nature08309","article-title":"Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance","volume":"461","author":"Ge","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.revmed.2010.10.354_bib0020","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1038\/ng.447","article-title":"IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy","volume":"41","author":"Suppiah","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.revmed.2010.10.354_bib0025","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/ng.449","article-title":"Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C","volume":"41","author":"Tanaka","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.revmed.2010.10.354_bib0030","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/nature08463","article-title":"Genetic variation in IL28B and spontaneous clearance of hepatitis C virus","volume":"461","author":"Thomas","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.revmed.2010.10.354_bib0035","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2010.04.013","article-title":"Interleukin-28B polymorphism improves viral kinetics and is the strongest pretreatment predictor of sustained virologic response in genotype 1\u00a0hepatitis C virus","volume":"139","author":"Thompson","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.revmed.2010.10.354_bib0040","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1053\/j.gastro.2009.12.056","article-title":"Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study","volume":"138","author":"Rauch","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.revmed.2010.10.354_bib0045","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1053\/j.gastro.2010.02.009","article-title":"Replicated association between an IL28B gene variant and a sustained response to pegylated interferon and ribavirin","volume":"138","author":"McCarthy","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.revmed.2010.10.354_bib0050","doi-asserted-by":"crossref","first-page":"S451","DOI":"10.1016\/S0168-8278(10)61168-3","article-title":"IL-28\u00a0gene variation predicts who will respond to interferon-based treatment of chronic hepatitis C in a French cohort","volume":"52","author":"Halfon","year":"2010","journal-title":"J Hepatol"},{"key":"10.1016\/j.revmed.2010.10.354_bib0055","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/hep.23624","article-title":"Interleukin-28B genetic variants and hepatitis virus infection by different viral genotypes","volume":"52","author":"Montes-Cano","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.revmed.2010.10.354_bib0060","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1086\/656235","article-title":"Prediction of response to pegylated interferon plus ribavirin by IL28B gene variation in patients coinfected with HIV and hepatitis C virus","volume":"51","author":"Pineda","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.revmed.2010.10.354_bib0065","doi-asserted-by":"crossref","first-page":"S468","DOI":"10.1016\/S0168-8278(10)61202-0","article-title":"IL28B polymorphism is significantly correlated with IFN anti-viral effectiveness already on first day of pegylated interferon-a and ribavirin therapy of chronic HCV infection","volume":"52","author":"Neumann","year":"2010","journal-title":"J Hepatol"},{"key":"10.1016\/j.revmed.2010.10.354_bib0070","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2010.05.079","article-title":"An IL28B polymorphism determines treatment response of hepatitis C virus genotype 2\u00a0or 3\u00a0patients who do not achieve a rapid virologic response","volume":"139","author":"Mangia","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.revmed.2010.10.354_bib0075","doi-asserted-by":"crossref","first-page":"F23","DOI":"10.1097\/QAD.0b013e3283391d6d","article-title":"Association of a single nucleotide polymorphism near the interleukin-28B gene with response to hepatitis C therapy in HIV\/hepatitis C virus-coinfected patients","volume":"24","author":"Rallon","year":"2010","journal-title":"AIDS"},{"key":"10.1016\/j.revmed.2010.10.354_bib0080","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1016\/S0168-8278(10)60127-4","article-title":"IL28B polymorphism is associated with jaundice during acute HCV infection and is a strong predictor for spontaneous clearance in the prospective German anti-D cohort","volume":"52","author":"Tillmann","year":"2010","journal-title":"J Hepatol"},{"key":"10.1016\/j.revmed.2010.10.354_bib0085","doi-asserted-by":"crossref","unstructured":"Grebely J, Petoumenos K, Hellard M, Matthews GV, Suppiah V, Applegate T, et al. Potential role for interleukin-28B genotype in treatment decision-making in recent hepatitis C virus infection. Hepatology 2010;52:1216\u201324.","DOI":"10.1002\/hep.23850"}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866310013949?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866310013949?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:27:15Z","timestamp":1759336035000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0248866310013949"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":17,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["S0248866310013949"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2010.10.354","relation":{},"ISSN":["0248-8663"],"issn-type":[{"value":"0248-8663","type":"print"}],"subject":[],"published":{"date-parts":[[2011,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Polymorphisme de l\u2019IL-28B et infection par le virus de l\u2019h\u00e9patite C\u00a0: impact sur la clairance virale prolong\u00e9e, spontan\u00e9e et apr\u00e8s traitement antiviral","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2010.10.354","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Published by Elsevier Masson SAS","name":"copyright","label":"Copyright"}]}}